Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_assertion type Assertion NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_head.
- NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_assertion description "[Mesothelin (MSLN) and cancer antigen125/mucin 16 (CA125/MUC16) are potential biomarkers for pancreatic cancer (PC) that are co-overexpressed at the invading edges of PC tissues, and their expression correlates with poor survival rates.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_provenance.
- NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_assertion evidence source_evidence_literature NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_provenance.
- NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_assertion SIO_000772 23694968 NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_provenance.
- NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_assertion wasDerivedFrom befree-20150227 NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_provenance.
- NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_assertion wasGeneratedBy ECO_0000203 NP962790.RAY0IOaHMAxZ8i_FaxVgdOEUxDg2-x0fYEBUCeANrmC5A130_provenance.